The stock's rise snapped a three-day losing streak.

7 out of 10 employed respondents have called in sick at least once in their career due to poor sleep.18% of couples reported sleeping in separate ...

ResMed (NYSE:RMD) has had a rough month with its share price down 7.5%. However, stock prices are usually driven by ...

ResMed Inc. (RMD), headquartered in San Diego, California, manufactures, distributes, and markets medical devices and ...

ResMed’s strong demand for AirSense 11 boosts its earnings outlook. Learn why RMD stock is undervalued with growth opportunities in the sleep apnea market.

Shares of ResMed (RMD) have been struggling lately and have lost 7.1% over the past two weeks. However, a hammer chart ...

ResMed has grown into a company that specialises in non-invasive technology solutions that improve sleep health worldwide.

Shares of ResMed Inc. RMD slipped 1.03% to $230.58 Tuesday, on what proved to be an all-around great trading session for the ...

ResMed reported robust earnings for the second quarter of fiscal 2025, surpassing expectations and showcasing strong growth in revenue and profitability. The great quarter was driven by high ...

ResMed is taking a “smart devices” and Big Data approach to further entrench itself as one of the two leading players in the global obstructive sleep apnea, or OSA, market. With cloud ...

Have you been paying attention to shares of ResMed (RMD)? Shares have been on the move with the stock up 12.8% over the past month. The stock hit a new 52-week high of $263.05 in the previous session.

New insights from 30,026 people across 13 markets show the global scale of poor sleep and its impact on health, work, and relationships7 out of 10 employed respondents have called in sick at least onc ...